{"id":6857,"date":"2025-02-13T09:59:38","date_gmt":"2025-02-13T09:59:38","guid":{"rendered":"https:\/\/haavind.no\/en\/?p=6857"},"modified":"2025-02-21T09:16:24","modified_gmt":"2025-02-21T09:16:24","slug":"pharma-report-winter-edition-2025","status":"publish","type":"post","link":"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/","title":{"rendered":"Pharma Report Winter Edition 2025"},"content":{"rendered":"\t<div class=\"template-post alignwide wp-block-dekode-hero\">\n\t\t<div class=\"hero__inner\">\n\t\t\t<div class=\"hero__inner_blocks\">\n\t\t\t\t\n<h1 class=\"wp-block-post-title\">Pharma Report Winter Edition 2025<\/h1>\n\n\n<p>We are proud to present the Winter 2025 edition of Haavind\u2019s Pharma Report. Pharma Report is a retrospective, report on legal developments in Norway relevant for the pharmaceutical sector, covering topics both within regulatory affairs and intellectual property. The report has been published since 2016.<\/p>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div><\/div>\n\t\t\t\t\t<div class=\"post-meta\">\n\t\t\t\t\t\t<span class=\"info-small\">13 February, 2025 \u00b7 2 min. reading time<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\n\n<div class=\"alignleft wp-block-haavind-byline\">\n\t\t\t\t<span class=\"author-tag\">Contact person<\/span>\n\t\t\t\t<div class=\"authors\"><a href=\"https:\/\/haavind.no\/en\/people\/hakon-austdal\/\" class=\"t2-byline__author-link\">\n\t\t\t\t<div class=\"author-inner\">\n\t\t\t\t\t<div class=\"author-inner__image\"><img loading=\"lazy\" decoding=\"async\" width=\"233\" height=\"300\" src=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-233x300.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-233x300.jpg 233w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-768x989.jpg 768w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-795x1024.jpg 795w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal.jpg 800w\" sizes=\"(max-width: 233px) 100vw, 233px\" \/><\/div>\n\t\t\t\t\t<div>\n\t\t\t\t\t\t<span class=\"name\">H\u00e5kon Austdal<\/span>\n\t\t\t\t\t\t<span>Specialist Counsel<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/a><\/div>\n\t\t\t\t<div class=\"topics\">\n\t\t\t\t<span><\/span>\n\t\t\t\t<div><\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\n<figure class=\"wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"2000\" height=\"1228\" src=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25.png\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"\" style=\"object-fit:cover;\" srcset=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25.png 2000w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25-300x184.png 300w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25-1024x629.png 1024w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25-768x472.png 768w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25-1536x943.png 1536w\" sizes=\"(max-width: 2000px) 100vw, 2000px\" \/><\/figure>\n\n\n<p>In this year\u2019s Winter edition, we are happy to present a summary of some of the most significant cases occurring in 2024. For those interested in pharmaceutical advertising, last year was indeed exciting. The report includes articles on the struggles of a pharmaceutical company&#8217;s fight to overturn at decision on violation fines for alleged breaches, as well as recent developments in pharmaceutical legislation. On the intellectual property side, the report includes articles on a Norwegian case on plausibility, a topic well known for those working with patent law, as well as the struggle for obtaining trademark registration for a well-known covid-19 vaccine.<\/p>\n\n\n\n<p>The report is authored by members of our Healthcare and Life Sciences team, which have extensive experience in advising pharmaceutical companies and other healthcare enterprises in all legal areas affecting this highly innovative and extensively regulated sector.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharma-Report-2025-1.pdf\">Pharma Report 2025<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":6859,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"sector":[],"speciality":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.2 (Yoast SEO v24.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma Report Winter Edition 2025 - Haavind EN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Report Winter Edition 2025\" \/>\n<meta property=\"og:url\" content=\"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Haavind EN\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-13T09:59:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-21T09:16:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25-1024x629.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"629\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"hagelid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hagelid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/\",\"url\":\"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/\",\"name\":\"Pharma Report Winter Edition 2025 - Haavind EN\",\"isPartOf\":{\"@id\":\"https:\/\/haavind.no\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25.png\",\"datePublished\":\"2025-02-13T09:59:38+00:00\",\"dateModified\":\"2025-02-21T09:16:24+00:00\",\"author\":{\"@id\":\"https:\/\/haavind.no\/en\/#\/schema\/person\/07f81b6289ea2b756e8275b6bb3a6c6b\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/#primaryimage\",\"url\":\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25.png\",\"contentUrl\":\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25.png\",\"width\":2000,\"height\":1228},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/haavind.no\/en\/#website\",\"url\":\"https:\/\/haavind.no\/en\/\",\"name\":\"Haavind EN\",\"description\":\"-\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/haavind.no\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/haavind.no\/en\/#\/schema\/person\/07f81b6289ea2b756e8275b6bb3a6c6b\",\"name\":\"hagelid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haavind.no\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2e8411e72bebc6a08cf18a47806de0f9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2e8411e72bebc6a08cf18a47806de0f9?s=96&d=mm&r=g\",\"caption\":\"hagelid\"},\"url\":\"https:\/\/haavind.no\/en\/author\/hagelid\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma Report Winter Edition 2025 - Haavind EN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/","og_locale":"en_US","og_type":"article","og_title":"Pharma Report Winter Edition 2025","og_url":"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/","og_site_name":"Haavind EN","article_published_time":"2025-02-13T09:59:38+00:00","article_modified_time":"2025-02-21T09:16:24+00:00","og_image":[{"width":1024,"height":629,"url":"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25-1024x629.png","type":"image\/png"}],"author":"hagelid","twitter_card":"summary_large_image","twitter_misc":{"Written by":"hagelid","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/","url":"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/","name":"Pharma Report Winter Edition 2025 - Haavind EN","isPartOf":{"@id":"https:\/\/haavind.no\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/#primaryimage"},"image":{"@id":"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25.png","datePublished":"2025-02-13T09:59:38+00:00","dateModified":"2025-02-21T09:16:24+00:00","author":{"@id":"https:\/\/haavind.no\/en\/#\/schema\/person\/07f81b6289ea2b756e8275b6bb3a6c6b"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haavind.no\/en\/pharma-report-winter-edition-2025\/#primaryimage","url":"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25.png","contentUrl":"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2025\/02\/Pharmareport25.png","width":2000,"height":1228},{"@type":"WebSite","@id":"https:\/\/haavind.no\/en\/#website","url":"https:\/\/haavind.no\/en\/","name":"Haavind EN","description":"-","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/haavind.no\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/haavind.no\/en\/#\/schema\/person\/07f81b6289ea2b756e8275b6bb3a6c6b","name":"hagelid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haavind.no\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2e8411e72bebc6a08cf18a47806de0f9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2e8411e72bebc6a08cf18a47806de0f9?s=96&d=mm&r=g","caption":"hagelid"},"url":"https:\/\/haavind.no\/en\/author\/hagelid\/"}]}},"_links":{"self":[{"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/posts\/6857"}],"collection":[{"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/comments?post=6857"}],"version-history":[{"count":3,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/posts\/6857\/revisions"}],"predecessor-version":[{"id":6874,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/posts\/6857\/revisions\/6874"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/media\/6859"}],"wp:attachment":[{"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/media?parent=6857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/categories?post=6857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/tags?post=6857"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/sector?post=6857"},{"taxonomy":"speciality","embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/speciality?post=6857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}